First Light Asset Management, LLC Bellus Health Inc. Transaction History

First Light Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$7.14 - $8.53 $4.74 Million - $5.66 Million	663,443 Added 28.15%	3,020,393 $21.7 Million
Q4 2022 Feb 14, 2023	SELL	$8.22 - $10.76 $204,735 - $267,999	-24,907 Reduced 1.05%	2,356,950 $19.4 Million
Q3 2022 Nov 14, 2022	SELL	$8.95 - $12.0 $234,642 - $314,604	-26,217 Reduced 1.09%	2,381,857 $25.2 Million
Q2 2022 Aug 12, 2022	SELL	$6.46 - $10.02 $537,917 - $834,355	-83,269 Reduced 3.34%	2,408,074 $22.3 Million
Q1 2022 May 13, 2022	BUY	$5.56 - $7.99 $916,371 - $1.32 Million	164,815 Added 7.08%	2,491,343 $17.1 Million
Q4 2021 Feb 14, 2022	BUY	$5.26 - $8.3 $12.2 Million - $19.3 Million	2,326,528 New	2,326,528 $18.7 Million

128K

Ticker BLU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,793,000
Description
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on First Light Asset Management, LLC with notifications on news.